![Bill Colone](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Profil
Bill Colone is currently the Chief Executive Officer at Singlepass, Inc. He was previously the Chief Executive Officer at UroDev Medical.
Postes actifs de Bill Colone
Sociétés | Poste | Début |
---|---|---|
Singlepass, Inc.
![]() Singlepass, Inc. Medical SpecialtiesHealth Technology Singlepass, Inc. has developed a unique electrocautery device that improves the clinical outcomes of deep tissue biopsy procedures. The company is based in Lake Forest, CA. The patented, single-use device prevents and stops bleeding caused by tissue extraction by cauterizing the tissue channel. It is the only cautery device of its kind that can be used for biopsy procedures. Singlepass was founded by Peter Sunenshine and Kevin Hirsch. The CEO is Bill Colone. | Directeur Général | - |
Anciens postes connus de Bill Colone
Sociétés | Poste | Fin |
---|---|---|
UroDev Medical
![]() UroDev Medical Medical SpecialtiesHealth Technology UroDev Medical develops a urinary catheter that allows the patient to control the flow of urine by actuating a magnetic valve. The company was founded by Zach Mckinney and Derek Herrera in 2015 and is headquartered in San Clemente, CA. | Directeur Général | - |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Entreprise privées | 2 |
---|---|
UroDev Medical
![]() UroDev Medical Medical SpecialtiesHealth Technology UroDev Medical develops a urinary catheter that allows the patient to control the flow of urine by actuating a magnetic valve. The company was founded by Zach Mckinney and Derek Herrera in 2015 and is headquartered in San Clemente, CA. | Health Technology |
Singlepass, Inc.
![]() Singlepass, Inc. Medical SpecialtiesHealth Technology Singlepass, Inc. has developed a unique electrocautery device that improves the clinical outcomes of deep tissue biopsy procedures. The company is based in Lake Forest, CA. The patented, single-use device prevents and stops bleeding caused by tissue extraction by cauterizing the tissue channel. It is the only cautery device of its kind that can be used for biopsy procedures. Singlepass was founded by Peter Sunenshine and Kevin Hirsch. The CEO is Bill Colone. | Health Technology |